Perreault, S., larouche, V., Tabori, U., Hawkins, C., Lippe, S., Ellezam, B., . . . Jabado, N. (2020). CTNI-24. A PHASE 2 STUDY OF TRAMETINIB FOR PATIENTS WITH PEDIATRIC GLIOMA WITH ACTIVATION OF THE MAPK/ERK PATHWAY. TRAM-01. Neuro Oncol.
シカゴスタイル引用形Perreault, Sébastien, et al. "CTNI-24. A PHASE 2 STUDY OF TRAMETINIB FOR PATIENTS WITH PEDIATRIC GLIOMA WITH ACTIVATION OF THE MAPK/ERK PATHWAY. TRAM-01." Neuro Oncol 2020.
MLA引用形式Perreault, Sébastien, et al. "CTNI-24. A PHASE 2 STUDY OF TRAMETINIB FOR PATIENTS WITH PEDIATRIC GLIOMA WITH ACTIVATION OF THE MAPK/ERK PATHWAY. TRAM-01." Neuro Oncol 2020.
警告: この引用は必ずしも正確ではありません.